Viewing Study NCT02142218


Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2025-12-26 @ 3:52 AM
Study NCT ID: NCT02142218
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2016-09-29
First Post: 2014-05-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access Program With Nivolumab to Treat Melanoma
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module